A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Genentech, Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Montefiore Medical Center
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Travera Inc
Eli Lilly and Company
OncoC4, Inc.
Seagen Inc.
KaliVir Immunotherapeutics
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
International Agency for Research on Cancer
Arcus Biosciences, Inc.
AstraZeneca
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
Eli Lilly and Company
AstraZeneca
Terremoto Biosciences Inc.
Taiho Oncology, Inc.
Ensem Therapeutics
Centre Oscar Lambret
Merck Sharp & Dohme LLC
Mayo Clinic
National Cancer Institute (NCI)
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
The Institute of Molecular and Translational Medicine, Czech Republic
Daiichi Sankyo
Normunity AccelCo, Inc.
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
Amgen
Institut Curie
University of Oklahoma
Theravectys S.A.
Karolinska University Hospital
SystImmune Inc.
Daiichi Sankyo